FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+6.28%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$365M
AUM Growth
+$365M
(+15%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
11.92%
Top 10 Holdings %
Top 10 Hldgs %
51.36%
Holding
54
New
2
Increased
25
Reduced
15
Closed
2
Top Buys
| 1 |
Xencor
XNCR
|
$14.1M |
| 2 |
NeoGenomics
NEO
|
$12.8M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$10.5M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.66M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$6.63M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$9.04M |
| 2 |
MDCO
Medicines Co
MDCO
|
$8.16M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$5.93M |
| 4 |
MacroGenics
MGNX
|
$1.48M |
| 5 |
STRM
Streamline Health Solutions
STRM
|
$652K |
Sector Composition
| 1 | Healthcare | 84.02% |
| 2 | Communication Services | 4.08% |
| 3 | Energy | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $34.1M | 9.35% | 3,847,602 +1,439,672 | +60% | +$12.8M |
|
|
2
Nektar Therapeutics
NKTR
$568M
| $21M | 5.76% | 351,741 -151,452 | -30% | -$9.04M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $20.1M | 5.5% | 1,566,804 +97,343 | +7% | +$1.25M |
|
4
AtriCure
ATRC
$1.84B
| $19.6M | 5.38% | 1,075,447 +41,711 | +4% | +$761K |
|
|
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $16.4M | 4.49% | 670,904 +38,167 | +6% | +$931K |
|
6
Omnicell
OMCL
$1.5B
| $15.4M | 4.22% | 317,331 +19,112 | +6% | +$927K |
|
|
7
Ligand Pharmaceuticals
LGND
$3.15B
| $15.3M | 4.2% | 111,971 +48,625 | +77% | +$6.66M |
|
8
Harvard Bioscience
HBIO
$22M
| $15.3M | 4.2% | 4,638,651 +522,369 | +13% | +$1.72M |
|
|
IMMU
9
DELISTED
Immunomedics Inc
IMMU
| $15.3M | 4.19% | 944,404 -367,110 | -28% | -$5.93M |
|
|
MODN
10
DELISTED
MODEL N, INC.
MODN
| $14.9M | 4.08% | 944,125 +92,417 | +11% | +$1.46M |
|
|
11
Xencor
XNCR
$580M
| $14.1M | 3.88% | +644,764 | New | +$14.1M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $12.3M | 3.39% | 79,607 +5,137 | +7% | +$797K |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $10.8M | 2.95% | 155,904 +95,999 | +160% | +$6.63M |
|
|
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
| $10.5M | 2.88% | +444,004 | New | +$10.5M |
|
15
Halozyme
HALO
$8.56B
| $9.48M | 2.6% | 467,646 +21,800 | +5% | +$442K |
|
|
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $8.34M | 2.29% | 596,778 +34,401 | +6% | +$481K |
|
17
Dynavax Technologies
DVAX
$1.19B
| $7.77M | 2.13% | 415,573 +141,643 | +52% | +$2.65M |
|
18
Heron Therapeutics
HRTX
$207M
| $7.49M | 2.05% | 413,721 +20,216 | +5% | +$366K |
|
19
Globus Medical
GMED
$8.27B
| $7.25M | 1.99% | 176,457 -2,559 | -1% | -$105K |
|
|
BLUE
20
DELISTED
bluebird bio
BLUE
| $6.74M | 1.85% | 37,838 +1,753 | +5% | +$312K |
|
21
Codexis
CDXS
$246M
| $6.72M | 1.84% | 804,224 +459,234 | +133% | +$3.83M |
|
|
XENT
22
DELISTED
Intersect ENT, Inc
XENT
| $5.8M | 1.59% | 178,896 +8,699 | +5% | +$282K |
|
|
TLGT
23
DELISTED
Teligent, Inc
TLGT
| $5.46M | 1.5% | 1,503,127 +19,784 | +1% | +$71.8K |
|
24
QuidelOrtho
QDEL
$1.95B
| $5.2M | 1.43% | 119,901 -2,608 | -2% | -$113K |
|
25
Veracyte
VCYT
$2.39B
| $5.17M | 1.42% | 791,337 -50,622 | -6% | -$331K |
|